Cosopt
Product Images NDC 17478-605

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Cosopt (NDC 17478-605). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cos04 0007 01

Cos04 0007 01
Chemical structure diagram of COSOPT's active ingredient as shown in the image, depicting its molecular formula with various sulfur, oxygen, nitrogen, carbon, and hydrogen atoms connected by single and double bonds.*
FDA Label Image

Cos04 0007 02

Cos04 0007 02
Chemical structure of the active ingredient in COSOPT, an ophthalmic pharmaceutical product by Akorn. The diagram shows molecular components and bonds characteristic of the compound associated with COSOPT.*
FDA Label Image

Cos04 0007 03

Cos04 0007 03
An instructional diagram showing a person applying an eye drop. The image focuses on the hand holding the dropper above an open eye, illustrating the correct technique for eye drop administration.*
FDA Label Image

Cos04 0007 04

Cos04 0007 04
An instructional illustration showing how to administer COSOPT eye drops. The image depicts a hand holding the eye drop bottle above an eye to apply drops, with a close-up inset highlighting the drop falling into the eye.*
FDA Label Image

Cos04 0007 05

Cos04 0007 05
COSOPT ophthalmic solution 2%/0.5% (dorzolamide hydrochloride 22.3 mg/mL and timolol maleate 6.8 mg/mL) in a 10 mL bottle labeled by Akorn. The label includes storage instructions, dosage form, and distributor information.*
FDA Label Image

Cos04 0007 06

Cos04 0007 06
COSOPT ophthalmic solution 2% / 0.5% packaged in a 10 mL sterile bottle label by Akorn. The label states it contains dorzolamide hydrochloride 22.3 mg/mL and timolol maleate 6.8 mg/mL. It is indicated for topical eye application and includes storage instructions, inactive ingredients, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.